Caption Management, LLC Cyma Bay Therapeutics, Inc. Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.72 - $3.39 $34,400 - $67,800	20,000 Added 200.0%	30,000 $88,000
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $27,700 - $36,400	10,000 New	10,000 $31,000
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $298,468 - $650,876	-89,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $126,759 - $382,075	89,900 New	89,900 $314,000
Q3 2019 Nov 14, 2019	SELL	$5.12 - $7.21 $153,600 - $216,300	-30,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$6.05 - $13.66 $181,500 - $409,800	30,000 New	30,000 $215,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.